Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Pharmacotherapy of resistant arterial hypertension

Шепелева Н. Å., Родионов А. В., Фомин В. В.
Терапевтический архив
Т. 90, Вып. 4, С. 4-7
Опубликовано: 2018
Тип ресурса: Статья

DOI:10.26442/terarkh20189044-7

Аннотация:
Pharmacotherapy of resistant arterial hypertension represents a serious problem, because today there are no clear algorithms of action in this clinical situation. The review discusses the key works in which the authors propose a solution to this problem. The variants of a differentiated approach to treatment based on hemodynamic type, plasma renin activity, as well as a number of empirical strategies, including the predominant use of mineralocorticoid receptor antagonists, are discussed. © 2018 Media Sphera Publishing Group. All rights reserved.
Ключевые слова:
Pharmacotherapy; Resistant arterial hypertension; Treatment
antihypertensive agent; mineralocorticoid antagonist; renin; human; hypertension; Antihypertensive Agents; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Renin
Язык текста: Русский
ISSN: 2309-5342
Шепелева Н. Å.
Родионов А. В. Антон Владимирович 1976-
Фомин В. В. Виктор Викторович 1978-
Shepeleva N. Å.
Rodionov A. V. Anton Vladimirovich 1976-
Fomin V. V. Viktor Viktorovich 1978-
Pharmacotherapy of resistant arterial hypertension
Текст визуальный непосредственный
Терапевтический архив
Медицинское маркетинговое агентство "МедиаМедика"
Т. 90, Вып. 4 С. 4-7
2018
Статья
Pharmacotherapy Resistant arterial hypertension Treatment
antihypertensive agent mineralocorticoid antagonist renin human hypertension Antihypertensive Agents Humans Hypertension Mineralocorticoid Receptor Antagonists Renin
Pharmacotherapy of resistant arterial hypertension represents a serious problem, because today there are no clear algorithms of action in this clinical situation. The review discusses the key works in which the authors propose a solution to this problem. The variants of a differentiated approach to treatment based on hemodynamic type, plasma renin activity, as well as a number of empirical strategies, including the predominant use of mineralocorticoid receptor antagonists, are discussed. © 2018 Media Sphera Publishing Group. All rights reserved.